Press releaseGlobe Newswire
Surrozen
SRZN · NASDAQ
$25.14+$1.30 (+5.45%)TodayMarket closed ·
Prev close $23.84
Latest news
- Press releaseGlobe Newswire
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
- NewsAvi Kapoor
Scholastic Posts Downbeat Q1 Results, Joins Legacy Education, Zscaler And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
- NewsAvi Kapoor
Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Crude Oil Rises Over 4%; Darden Earnings Miss Views
- NewsVandana Singh
Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy
- NewsAvi Kapoor
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000
- Press releaseGlobe Newswire
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
- Press releaseGlobe Newswire
Surrozen to Present at Upcoming Healthcare Investor Conferences
- Press releaseGlobe Newswire
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Surrozen to Present at Upcoming Healthcare Investor Conference
- Press releaseGlobe Newswire
Surrozen to Present at Upcoming Healthcare Investor Conference
- News
Earnings Scheduled For May 6, 2026
- Press releaseGlobe Newswire
Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Press releaseGlobe Newswire
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
Surrozen Q2 EPS $2.55 Beats $(1.11) Estimate, Sales $983.000K
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.